Alzamend Neuro, Inc. (ALZN)
1.94
-0.03
(-1.52%)
USD |
NASDAQ |
Feb 10, 16:00
1.94
0.00 (0.00%)
After-Hours: 16:12
Alzamend Neuro Total Assets (Quarterly) : 5.092M for Oct. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 1.753B |
| Allogene Therapeutics, Inc. | 439.77M |
| Embecta Corp. | 1.064B |
| BrightSpring Health Services, Inc. | 6.049B |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.7175M |
| Shareholders Equity (Quarterly) | 4.374M |
| Current Ratio | 6.580 |